CompletedNot Applicable

In Vivo Evaluation of Growth and Risk of Rupture of Dilated Ascending Aorta Using 4D Cardiac Magnetic Resonance

France41 participantsStarted 2017-10-11

Plain-language summary

Ascending aorta aneurysmal disease is common and can be complicated by dissection or rupture. There is substantial variation in individual aneurysm progression: established risk factors for an accelerated aneurysm growth rate include initial size or localization, the presence of aortic valve disease, congenital bicuspid aortic valve or connective tissue disorders.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years. * Supra-coronary aortic diameter measured by CT-scan or transthoracic/trans-esophageal echocardiography between 40 and 45 mm in case of presence of aortic valve disease, bicuspid aortic valve or connective tissue disease and between 40 and 50 mm in case of absence of aortic valve disease, bicuspid aortic valve disease or connective tissue. * Informed consent for participation in the study Exclusion Criteria: * Contraindication to MRI * Patient's refusal to participate in the study and / or inability to express agreement or signing the informed consent.

What they're measuring

Correlation between wall shear stress (WSS) and aorta diameter in patient with dilated ascending aorta

Timeframe: From baseline to 1 year

Trial details

NCT IDNCT03172390

SponsorCentre Hospitalier Universitaire de Saint Etienne

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-04-11

View on ClinicalTrials.gov More Aortic Rupture trials